Tonix Pharmaceuticals Announces Plan to Develop TNX-601 CR Tablets for Once-Daily Treatment of Major Depressive Disorder, in Addition to PTSD, After Successful Completion of Phase 1 Pharmacokinetic Study - GlobeNewswire

Submitted by Anonymous (not verified) on Mon, 12/16/2019 - 20:15